Chairman, CEO

Robert Brooks serves as Chairman and Chief Executive Officer of the Company. Robert brings over 30 years of biotechnology, financial and legal experience. He also serves as Founder, Chairman and Chief Executive Officer of Alphageneron Pharmaceuticals, a clinical stage company focused on natural killer (NK) cell and antibody-based therapies. In 2015, he founded and served as Chief Executive Officer of Aurora Biopharma, a biotechnology company with a mission to develop CAR T cell therapy for solid tumors. In 2012, he founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage biotechnology company focused on developing dendritic cell cancer vaccines. From 2000 to 2010, Mr. Brooks practiced corporate law, representing private and publicly listed companies. From 1987 until 1999, he was employed in the financial industry, and involved in investment banking. He serves on the Board of Directors of Medtherapy, Inc., a start-up global cell and gene manufacturer.

He holds a Juris Doctorate (JD) degree from the University of Miami, Florida, and undergraduate Bachelor of Science degree, Cum Laude, in Biology.